Why Is Kosmos Energy Stock Trading Higher Today?
Kosmos Energy (NYSE: KOS) shares are trading higher on Monday after the company reported better-than-expected Q4 results.
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session.
Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Kosmos Energy Q4 Adj EPS $0.23 Beats $0.14 Estimate, Sales $563.72M Beat $505.61M Estimate
Kosmos Energy (NYSE:KOS) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.14 by 64.29 percent. This is a 76.92 percent increase over earnings of $0.13 per share from the same
Benchmark Initiates Coverage On Kosmos Energy with Buy Rating, Announces Price Target of $10
Benchmark analyst Subash Chandra initiates coverage on Kosmos Energy (NYSE:KOS) with a Buy rating and announces Price Target of $10.
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell
• NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Kosmos Energy Q3 Adj EPS $0.19 Up From $(0.11) YoY, Sales $456.10M Up From $200.54M YoY
Kosmos Energy (NYSE:KOS) reported quarterly earnings of $0.19 per share. This is a 272.73 percent increase over losses of $(0.11) per share from the same period last year. The company reported $456.10 million in sales
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday’s Mid-Day Session
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.